S

Spectrum Pharmaceuticals Inc
F:NTR

Watchlist Manager
Spectrum Pharmaceuticals Inc
F:NTR
Watchlist
Price: 0.925 EUR Market Closed
Market Cap: 189.9m EUR

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of NTR.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NTR Intrinsic Value
Not Available
S
Base Case Scenario
Compare NTR to

Fundamental Analysis

Spectrum Pharmaceuticals Inc
F:NTR
US
Biotechnology
Market Cap
189.9m EUR
IPO
Sep 26, 1996
US
Biotechnology
Market Cap
189.9m EUR
IPO
Sep 26, 1996
Price
€false
EPS
$false
Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about NTR?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Spectrum Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Spectrum Pharmaceuticals Inc

Current Assets 105.4m
Cash & Short-Term Investments 56.1m
Receivables 33.6m
Other Current Assets 15.6m
Non-Current Assets 2.3m
PP&E 2.1m
Other Non-Current Assets 245k
Efficiency

Free Cash Flow Analysis
Spectrum Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Spectrum Pharmaceuticals Inc

Revenue
25.7m USD
Cost of Revenue
-2.9m USD
Gross Profit
22.9m USD
Operating Expenses
-86.4m USD
Operating Income
-63.5m USD
Other Expenses
-1.5m USD
Net Income
-65m USD
Fundamental Scores

NTR Profitability Score
Profitability Due Diligence

Spectrum Pharmaceuticals Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional Gross Margin
ROE is Increasing
Sustainable 3Y Average Gross Margin
35/100
Profitability
Score

Spectrum Pharmaceuticals Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

NTR Solvency Score
Solvency Due Diligence

Spectrum Pharmaceuticals Inc's solvency score is 36/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
Average D/E
36/100
Solvency
Score

Spectrum Pharmaceuticals Inc's solvency score is 36/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NTR Price Targets Summary
Spectrum Pharmaceuticals Inc

There are no price targets for NTR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for NTR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y